Characterization of an HIV type 1 strain with preferential replication in adherent cells

AIDS Research and Human Retroviruses

Volumn 18, Issue 9, 2002, Pages 641-647

  Serra, Caterina ^a   Mameli, Giuseppe ^a   Biolchini, Adriana ^a   Ziccheddu, Maria ^a   Curreli, Sabrina ^a   Arru, Giannina ^a   Dolei, Antonina ^a  

^a UNIVERSITY OF SASSARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ENVELOPE PROTEIN; MUTANT PROTEIN; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR SP1;

ADHERENT CELL; ARTICLE; BINDING SITE; CELL DIVISION; CELL LINE; CONTROLLED STUDY; EPITHELIUM CELL; FIBROBLAST; HELA CELL; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS E; HUMAN IMMUNODEFICIENCY VIRUS T; LONG TERMINAL REPEAT; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; TISSUE; VIRUS ADSORPTION; VIRUS CHARACTERIZATION; VIRUS REPLICATION; VIRUS STRAIN;

BASE SEQUENCE; EPITHELIAL CELLS; FIBROBLASTS; GENE PRODUCTS, TAT; HELA CELLS; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; RNA, VIRAL; VIRUS REPLICATION;

EID: 0036434099     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922202760019338     Document Type: Article

References (47)

1. Qureshi MN, Barr CE, Hewlitt I, Boorstein R, Kong F, Bagasra O, Bobroski LE, and Joshi B: Detection of HIV in oral mucosal cells. Oral Dis 1997;3(Suppl. 1):S73-S78.
2. Biolchini A, Curreli S, Ziccheddu M, Serra C, and Dolei A: Opposite effects of interferon γ on CCR5 and CXCR4 expression and on entry of M- and T-tropic HIV in epithelial cells. AIDS 2000;14:7-9.
3. Fantini J, Cook DG, Nathanson N, Spitalnik SL, and GonzalezScarano F: Infection of colonic epithelial cell lines by type 1 human immunodeficiency virus is associated with cell surface expression of galactosylceramide, a potential alternative gpl20 receptor. Proc Natl Acad Sci USA 1993;90:2700-2704.
4. Nelson JA, Wiley CA, Reynolds-Kohler C, Reese CE, Margaretten W, and Levy JA: Human immunodeficiency virus detected in bowel epithelium from a patient with gastrointestinal symptoms. Lancet 1988;i:259-262.
5. Ullrich R, Schmidt W, Zippel T, Schneider T, Zeitz M, and Riecken EO: Mucosal HIV infection. Pathobiology 1998;66:145-150.
6. El Messaoudi K, Thiry LF, Liesnard C, Van Tieghem N, Bollen A, and Moguilevsky N: A human milk factor susceptible to cathepsin D inhibitors enhances human immunodeficiency virus type 1 infectivity and allows virus entry into a mammary epithelial cell line. J Virol 2000;74:1004-1007.
7. Southern SO: Milk-borne transmission of HIV. Characterization of productively infected cells in breast milk and interactions between milk and saliva. J Hum Virol 1998;1:328-337.
8. Toniolo A, Serra C, Conaldi PG, Basolo F, Falcone V, and Dolei A: Productive HIV-1 infection of normal human mammary epithelial cells. AIDS 1995;9:859-866.
9. Barboza A, Castro BA, Whalen M, Moore CCD, Parkin JS, Miller WL, Gonzalez-Scarano F, and Levy JA: Infection of cultured human adrenal cells by different strains of HIV. AIDS 1992;12: 1437-1443.
10. Han Y, Ventura CL, Black KP, Cummins JE, Hall SD, and Jackson S: Productive human immunodeficiency virus-1 infection of epithelial cell lines of salivary gland origin. Oral Microbiol Immunol 2000;15:82-88.
11. Bruggeman LA, Ross MD, Tanji N, Cara A, Dikman S, Gordon RE, Burns GC, D'Agati VD, Winston JA, Klotman ME, and Klotman PE: Renal epithelium is a previously unrecognized site of HIV-1 infection. J Am Soc Nephrol 2000;11:2079-2087.
12. Conaldi PG, Bottelli A, Wade-Evans A, Biancone L, Baj A, Cantaluppi V, Serra C, Dolei A, Toniolo A, and Camussi G: HIV-persistent infection and cytokine induction in mesangial cells: A potential mechanism for HIV-associated glomerulosclerosis. AIDS 2000;14:2045-2047.
13. Ray PE, Liu XH, Henry D, Dye L, Xu L, Orenstein JM, and Schuztbank TE: Infection of human primary renal epithelial cells with HIV-1 from children with HIV-associated nephropathy. Kidney Int 1998;53:1217-1229.
14. Cao Y, Dieterich D, Thomas PA, Huang Y, Mirabile M, and Ho DD: Identification and quantitation of HIV-1 in liver of patients with AIDS. AIDS 1992;6:65-70.
15. Braun J, Valentin H, Nugeyre MT, Ohayon H, Gounon P, and Barré-Sinoussi F: Productive and persistent infection of human thymic epithelial cells in vitro with HIV-1. Virology 1996; 225:413-418.
16. Canki M, Sparrow JR, Chao W, Potash MJ, and Volsky DJ: Human immunodeficiency virus type 1 can infect human retinal pigment epithelial cells in culture and alter the ability of the cells to phagocytose rod outer segment membranes. AIDS Res Hum Retroviruses 2000;16:453-463.
17. Dolei A, Arca MV, Tilocca F, Pietravalle M, Alemanno L, Toniolo A, and Ameglio F: Mutual interactions of HIV-1 and cytokines in adherent cells during acute infection. Arch Virol 1994;134:157-168.
18. Dezzutti CS, Guenthner PC, Cummins JE, Cabrera T, Marshall JH, Dillberger A, and Lal RB: Cervical and prostate primary epithelial cells are not productively infected but sequester human immunodeficiency virus type 1. J Infect Dis 2001;183:1203-1204.
19. Greenhead P, Hayes P, Watts PS, Laing KG, Griffin GE, and Shattock RJ: Parameters of human immunodeficiency virus infection of human cervical tissue and inhibition by vaginal virucides. J Virol 2000;74:5577-5586.
20. Dolei A, Serra C, Arca MV, and Toniolo A: Acute HIV-1 infection of CD4-positive human lung fibroblasts. AIDS 1992;6:232-234.
21. Dolei A, Serra C, Arca MV, Tilocca F, Riva E, Antonelli G, Dianzani F, and Toniolo A: Infectious virus with reduced cytopathogenicity resulting from persistent infection of normal lung fibroblasts by HIV type 1 strains. AIDS Res Human Retroviruses 1994;10:1089-1095.
22. β-chemokines. AIDS 1998;12:183-190.
23. Conaldi PG, Biancone L, Bottelli A, Wade-Evans A, Racusen LC, Boccellino M, Orlandi V, Serra C, Camussi G, and Toniolo A: HIV-1 kills renal tubular epithelial cells in vitro by triggering an apoptotic pathway involving caspase activation and Fas upregulation. J Clin Invest 1998;102:2041-2049.
24. Capobianchi MR, Serra C, Abbate I, Marongiu P, Castilletti C, Tilocca F, Dianzani F, and Dolei A: Treatment of HIV-infected fibroblasts with DR-inductive cytokines leads to infectious virions with newly acquired DR. AIDS 1994;8:1731-1733.
25. Dolei A, Serra C, Biolchini A, Curreli S, Marongiu P, Gomes E, and Ameglio F: HIV-permissive cells from solid tissues: Cytokine induction and effects. Perspect Drugs Discov Design 1996;5:90-101.
26. Kuiken CL, Zwart G, Baan E, Coutinho RA, van den Hoek JA, and Goudsmit J: Increasing antigenic and genetic diversity of the V3 variable domain of the human immunodeficiency virus envelope protein in the course of the AIDS epidemic. Proc Natl Acad Sci USA 1993;90:9061-9065.
27. Yedavalli VRK, Chappey C, and Ahmad N: Maintenance of an intact human immunodeficiency virus type 1 vpr gene following mother-to-infant transmission. J Virol 1998;72:6937-6943.
28. Montano MA, Novitsky VA, Blackard JT, Cho NL, Katzenstein DA, and Essex M: Divergent transcriptional regulation among expanding human immunodeficiency virus type 1 subtypes. J Virol 1997;71:8657-8665.
29. Chesebro B, Wehrly K, Nishio J, and Perryman S: Mapping of independent V3 envelope determinants of human immunodeficienc y virus type 1 macrophage tropism and syncytium formation in lymphocytes. J Virol 1996;70:9055-9059.
30. κB binding sites. J Virol 1997;71:1651-1656.
31. Estable MC, Bell B, Merzouki A, Montaner JS, O'Shaughnessy MV, and Sadowski IJ: Human immunodeficiency virus type 1 long terminal repeat variants from 42 patients representing all stages of infection display a wide range of sequence polymorphism and transcription activity. J Virol 1996;70:4053-4062.
32. Gaynor R: Cellular transcription factors involved in the regulation of HIV-1 gene expression. AIDS 1992;6:347-363.
33. Estable MC, Bell B, Hirst M, and Sadowski I: Naturally occurring human immunodeficiency virus type 1 long terminal repeats have a frequently observed duplication that binds RBF-2 and represses transcription. J Virol 1998;72:6465-6474.
34. Guo MM and Hildreth JE: HIV acquires functional adhesion receptors from host cells. AIDS Res Hum Retroviruses 1995;11:1007-1013.
35. Lawn SD, Roberts BD, Griffin GE, Folks TM, and Butera ST: Cellular compartments of human immunodeficiency virus type 1 replication in vivo: Determination by presence of virion-associated host proteins and impact of opportunistic infection. J Virol 2000; 74:139-145.
36. Paquette JS, Fortin JF, Blanchard L, and Tremblay MJ: Level of ICAM-1 surface expression on virus producer cells influences both the amount of virion-bound host ICAM-1 and human immunodeficiency virus type 1 infectivity. J Virol 1998;72:9329-9336.
37. Labrosse B, Treboute C, Brelot A, and Alizon M: Cooperation of the V1/V2 domains of human immunodeficiency virus type 1 gpl20 for interaction with the CXCR4 receptor. J Virol 2001;75:5457-5464.
38. Klaver B and Berkhout B: Premature strand transfer by the HIV-1 reverse transcriptase during strong-stop DNA synthesis. Nucleic Acids Res 1994;22:137-144.
39. Das AT, Klaver B, and Berkhout B: The 5′ and 3′ TAR dements of human immunodeficiency virus exert effects at several points in the virus life cycle. J Virol 1998;72:9217-9223.
40. Emiliani S, Delsert C, David C, and Devaux C: The long terminal repeat of the human immunodeficiency virus type 1 GER isolate shows a duplication of the TAR region. AIDS Res Hum Retroviruses 1994;10:1751-1752.
41. Ait-Khaled M, McLaughlin JE, Johnson MA, and Vincent VC: Distinct HIV-1 long terminal repeat quasispecies present in nervous tissues compared to that in lung, blood and lymphoid tissues of an AIDS patient. AIDS 1995;9:675-683.
42. κB binding to the HIV-1 LTR in kidney: Implications for HIV-associated nephropathy. Kidney Int 2001;59:2174-2181.
43. Fujinaga K, Cujec TP, Peng J, Garriga J, Price DH, Grana X, and Peterlin BM: The ability of positive transcription elongation factor b to transactivate human immunodeficiency virus transcription depends on a functional kinase domain, cyclin T1, and Tat. J Virol 1998;72:7154-7159.
44. κB-proximal Sp site III: Evidence for cell type-specific gene regulation and viral replication. Virology 2000;274:262-277.
45. Chun TW and Fauci AS: Latent reservoirs of HIV: Obstacles to the eradication of virus. Proc Natl Acad Sci USA 1999;96:10958-10961.
46. Schrager LK and D'Souza P: Cellular and anatomical reservoirs of HIV-1 in patients receiving potent antiretroviral combination therapy. JAMA 1998;280:67-71.
47. Siliciano JD and Siliciano RF: Latency and viral persistence in HIV-1 infection. J Clin Invest 2000;106:823-825.